(Total Views: 420)
Posted On: 04/15/2021 1:41:33 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Borel Fields #86739
The patient population was probably similar to baricitinib's other trial - most moderate, some severe, none critical. Matching up baricitinib against dexamethasone in that setting is rather quixotic.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)